Osteoporosis from Prevention to Treatment
 

In order to receive CME credit for this activity, please enter your name and address as indicated and answer the following questions. Your responses will be recorded and forwarded to Primary Care Network.

Name:
Degree:
Email:
Address:
City:
State:
Zip Code:
Phone: xxx-xxx-xxxx
Fax: xxx-xxx-xxxx


Post Test

Please answer the following questions by selecting the response you feel is correct for each question. Completion of this post-test will assist Primary Care Network in the measurement of educational outcomes. Thank you.

Hannah is 59 and has asthma; she has been somewhat difficult to treat. Her asthma is moderate to severe and she uses an inhaled corticosteroid/long acting beta agonist. She has a rescue inhaler but has needed oral corticosteroids intermittently for exacerbations with upper respiratory infections. She has been reading up on osteoporosis as her mom has been recently diagnosed with osteoporosis. She wonders if she needs a BMD test. According to guidelines all women over age 65 should have BMD testing, but what about Hannah? According to NOF guidelines, which younger postmenopausal women should have BMD testing?
   
 

A. Prior adult fracture

 

B. Family history

 

C. Weight < 127 pounds

 

D. Glucocorticoid therapy

 

E. A and C

 

F. B and D

 

G. A, B, and C

  H. All of the above
     

You sent Hannah for DEXA testing. She had BMD done of her lumbar spine (L1 – L4) and hip (total proximal femur and femoral neck). Her lowest T-score was -2.7. Which of the following options for osteoporosis prevention have been shown to prevent both vertebral and nonvertebral fractures?
 
 

A. Alendronate (Fosamax)

 

B. Ibandronate (Boniva)

 

C. Risedronate (Actonel)

  D. Raloxifene (Evista)
  E. A and C
  F. B and D
  G. All of the above
 
 


 
           

Home | Conferences | Partners | Online CME | Links | About Us | Become a Member | Research Opportunities | Needs Analysis
© 2006 Primary Care Network